These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 29878936)

  • 1. Therapeutic Drug Monitoring to Assess Drug Adherence in Assumed Resistant Hypertension: A Comparison With Directly Observed Therapy in 3 Nonadherent Patients.
    Feyz L; Bahmany S; Daemen J; van den Meiracker AH; Koch BCP; van Gelder T; Versmissen J
    J Cardiovasc Pharmacol; 2018 Aug; 72(2):117-120. PubMed ID: 29878936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic Drug Monitoring to Assess Drug Adherence in Assumed Resistant Hypertension: A Comparison With Directly Observed Therapy in Three Nonadherent Patients.
    Šíma M; Slanař O
    J Cardiovasc Pharmacol; 2019 Feb; 73(2):125. PubMed ID: 30531438
    [No Abstract]   [Full Text] [Related]  

  • 3. Single-Pill Triple Fixed Dose Combination Therapy with Single Component Drug Monitoring in Treatment-Resistant Hypertension: A Pilot Study.
    Kreutz R; Scholze J; Douros A
    Curr Vasc Pharmacol; 2018 Jan; 16(2):197-203. PubMed ID: 28828980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adherence to antihypertensive therapy and therapeutic dosage of antihypertensive drugs.
    Rabbia F; Fulcheri C; Di Monaco S; Covella M; Perlo E; Pappaccogli M; Veglio F
    High Blood Press Cardiovasc Prev; 2016 Dec; 23(4):341-345. PubMed ID: 27160721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-adherence to antihypertensive medication is very common among resistant hypertensives: results of a directly observed therapy clinic.
    Hameed MA; Tebbit L; Jacques N; Thomas M; Dasgupta I
    J Hum Hypertens; 2016 Feb; 30(2):83-9. PubMed ID: 25947275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic drug monitoring-guided definition of adherence profiles in resistant hypertension and identification of predictors of poor adherence.
    Avataneo V; De Nicolò A; Rabbia F; Perlo E; Burrello J; Berra E; Pappaccogli M; Cusato J; D'Avolio A; Di Perri G; Veglio F
    Br J Clin Pharmacol; 2018 Nov; 84(11):2535-2543. PubMed ID: 29971815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of drug compliance in patients with high blood pressure resistant to antihypertensive therapy.
    Waeber B; Feihl F
    EuroIntervention; 2013 May; 9 Suppl R():R29-34. PubMed ID: 23732152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adherence to medication and drug monitoring in apparent treatment-resistant hypertension.
    Eskås PA; Heimark S; Eek Mariampillai J; Larstorp AC; Fadl Elmula FE; Høieggen A
    Blood Press; 2016 Aug; 25(4):199-205. PubMed ID: 26729283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medication adherence and resistant hypertension.
    Hyman DJ; Pavlik V
    J Hum Hypertens; 2015 Apr; 29(4):213-8. PubMed ID: 25209307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adherence to Antihypertensive Treatment and the Blood Pressure-Lowering Effects of Renal Denervation in the Renal Denervation for Hypertension (DENERHTN) Trial.
    Azizi M; Pereira H; Hamdidouche I; Gosse P; Monge M; Bobrie G; Delsart P; Mounier-Véhier C; Courand PY; Lantelme P; Denolle T; Dourmap-Collas C; Girerd X; Michel Halimi J; Zannad F; Ormezzano O; Vaïsse B; Herpin D; Ribstein J; Chamontin B; Mourad JJ; Ferrari E; Plouin PF; Jullien V; Sapoval M; Chatellier G;
    Circulation; 2016 Sep; 134(12):847-57. PubMed ID: 27576780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistant hypertension: a practical clinical approach.
    Muxfeldt ES; de Souza F; Salles GF
    J Hum Hypertens; 2013 Nov; 27(11):657-62. PubMed ID: 23636008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How can resistant hypertension be identified and prevented?
    Solini A; Ruilope LM
    Nat Rev Cardiol; 2013 May; 10(5):293-6. PubMed ID: 23459606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential cost-effectiveness of therapeutic drug monitoring in patients with resistant hypertension.
    Chung O; Vongpatanasin W; Bonaventura K; Lotan Y; Sohns C; Haverkamp W; Dorenkamp M
    J Hypertens; 2014 Dec; 32(12):2411-21; discussion 2421. PubMed ID: 25255395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal sympathetic denervation in patients with treatment-resistant hypertension after witnessed intake of medication before qualifying ambulatory blood pressure.
    Fadl Elmula FE; Hoffmann P; Fossum E; Brekke M; Gjønnæss E; Hjørnholm U; Kjær VN; Rostrup M; Kjeldsen SE; Os I; Stenehjem AE; Høieggen A
    Hypertension; 2013 Sep; 62(3):526-32. PubMed ID: 23836798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment resistant hypertension and renal sympathetic denervation: drug adherence and the consolidation of blood pressure lowering effects.
    Kjeldsen SE; Os I; Mahfoud F
    EuroIntervention; 2013 May; 9 Suppl R():R7-9. PubMed ID: 23732159
    [No Abstract]   [Full Text] [Related]  

  • 16. Patients' Attitudes and Approaches to the Self-Management of Hypertension: Perspectives from an Australian Qualitative Study in Community Pharmacy.
    Bajorek B; Lemay K; Magin P; Roberts C; Krass I; Armour C
    High Blood Press Cardiovasc Prev; 2017 Jun; 24(2):149-155. PubMed ID: 28168358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adherence to Antihypertensive Therapy and Elevated Blood Pressure: Should We Consider the Use of Multiple Medications?
    Hedna K; Hakkarainen KM; Gyllensten H; Jönsson AK; Andersson Sundell K; Petzold M; Hägg S
    PLoS One; 2015; 10(9):e0137451. PubMed ID: 26359861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unsuccessfully Treated Hypertension: A Major Public Health Problem With a Potential Solution.
    Furberg CD; Sealey JE; Blumenfeld JD
    Am J Hypertens; 2017 Sep; 30(9):857-860. PubMed ID: 28482060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonadherence by Serum Drug Analyses in Resistant Hypertension: 7-Year Follow-Up of Patients Considered Adherent by Directly Observed Therapy.
    Halvorsen LV; Bergland OU; Søraas CL; Larstorp ACK; Hjørnholm U; Kjær VN; Kringen MK; Clasen PE; Haldsrud R; Kjeldsen SE; Rostrup M; Fadl Elmula FEM; Opdal MS; Høieggen A
    J Am Heart Assoc; 2022 Sep; 11(18):e025879. PubMed ID: 36073648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of patients with uncontrolled arterial hypertension--the role of electronic compliance monitoring, 24-h ambulatory blood pressure monitoring and Candesartan/HCTZ.
    Mengden T; Vetter H; Tousset E; Uen S
    BMC Cardiovasc Disord; 2006 Aug; 6():36. PubMed ID: 16942618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.